Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

Presentation TCT 2024

TCT 425: Impact of Coronary Lesion Complexity on 5-Year Outcomes After Bioresorbable Polymer Sirolimus-Eluting Stent Implantation: Insights From the e-ULTIMASTER Registry

Presenter: Shoichi Kuramitsu

October 29, 2024

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

Presentation TCT 2023

TCT 79: Impact of sex on clinical outcomes in patients undergoing complex percutaneous coronary angioplasty ((from the e-ULTIMASTER Study).

Presenter: Gemina Doolub

October 26, 2023

Presentation EuroPCR 2022

MASTER DAPT: Complex Percutaneous Coronary Intervention sub-analysis

Presenter: Pascal Vranckx

May 20, 2022

News Conference News EuroPCR 2022

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

Yael L. Maxwell

May 17, 2022

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

News Daily News

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

Caitlin E. Cox

September 15, 2021

News Conference News

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

Shelley Wood

August 30, 2021

News Conference News ESC 2021

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Shelley Wood

August 28, 2021

News Daily News

EVOLVE Short DAPT in Print: P2Y12 Decisions Can Safely Be Made Case-by-Case

Yael L. Maxwell

March 03, 2021

News Conference News AHA 2020

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Shelley Wood

November 15, 2020

News Conference News TCT 2020

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Shelley Wood

October 17, 2020

News Daily News

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

Caitlin E. Cox

October 08, 2020

Presentation JIM 2019

Ultimaster : Bulding the evidence for treatment of complex patients

Presenter: M. Valgimigli

February 14, 2019

News Conference News EuroPCR 2018

Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents

Shelley Wood

May 24, 2018

Presentation TCT 2017

PLLA-Based Biolimus A9 Elution II: From Nobori to Ultimaster Specifications and Results

Presenter: Ioannis Iakovou, Gert Richardt, Shigeru Saito

October 30, 2017

Presentation JIM 2017

Ultimaster DES: Evidence for Every Clinical Scenario

Presenter: Marco Valgimigli

February 09, 2017

News Conference News TCT 2016

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

Shelley Wood

November 07, 2016

Presentation TCT 2016

Stent Design and Comprehensive Data Review: From Nobori to Ultimaster Biolimus-Eluting Stents

Presenter: Dean J. Kereiakes, Pieter C. Smits, Shigeru Saito

October 30, 2016

Presentation JIM 2016

DES safety and DAPT: The Ultimaster DES

Presenter: Corrado Tamburino

February 10, 2016

Advertisement

TCT 425: Impact of Coronary Lesion Complexity on 5-Year Outcomes After Bioresorbable Polymer Sirolimus-Eluting Stent Implantation: Insights From the e-ULTIMASTER Registry

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

TCT 79: Impact of sex on clinical outcomes in patients undergoing complex percutaneous coronary angioplasty ((from the e-ULTIMASTER Study).

MASTER DAPT: Complex Percutaneous Coronary Intervention sub-analysis

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

More DAPT Duration Data, More Calls to Tailor to Individual Patients

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

EVOLVE Short DAPT in Print: P2Y12 Decisions Can Safely Be Made Case-by-Case

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

Ultimaster : Bulding the evidence for treatment of complex patients

Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents

PLLA-Based Biolimus A9 Elution II: From Nobori to Ultimaster Specifications and Results

Ultimaster DES: Evidence for Every Clinical Scenario

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

Stent Design and Comprehensive Data Review: From Nobori to Ultimaster Biolimus-Eluting Stents

DES safety and DAPT: The Ultimaster DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content